{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "CME",
  "name": "CME Group Inc.",
  "url": "https://orbyd.app/dossiers/CME/",
  "json_url": "https://orbyd.app/dossiers/CME.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Incumbent-exchange pivot into event contracts: the 2026-07-29 FutureSports index-futures deal plus record July ADV of 27M contracts (+23% YoY, reported 2026-08-04), against a stock still 16.9% below its 52-week high of $317.22. Operating records are not producing price highs; the leg only confirms above the 200-day near $278.50, and the 2026-08-26 CFTC comment close is the near-term gate.",
  "invalidation_trigger": "A weekly close below $250 loses the 50-day average and unwinds the post-Q2 recovery leg. Secondary: FSPI sports index futures failing to list by 2026-09-30 despite the \"this summer\" guidance in the 2026-07-29 FutureSports release.",
  "catalyst_date": "2026-08-26",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "prediction-markets-betting",
    "crypto-exchanges-financials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Trailing dividend of $11.35/share (4.30% yield, 2026-08-08) includes the January variable payout; the recurring quarterly rate is $1.30.",
    "CME publishes ADV monthly in the first business days of the following month, so volume evidence arrives at higher frequency than quarterly earnings.",
    "New contracts reach the market via CFTC self-certification (Reg 40.2) or voluntary review (Reg 40.3); the 40.3 path runs up to 45 days, extendable to 90.",
    "Revenue is levered to volatility across rates, energy and equity index; a quiet macro tape compresses ADV independent of any product news."
  ],
  "body_markdown": "## Current Thesis\nThe leg on offer is an incumbent clearinghouse bolting an event-contract growth story onto a franchise that is already printing record throughput. On 2026-07-29 CME announced a long-term partnership with FutureSports to list the first futures and options on sports performance indexes (FSPI), cash-settled, monthly and quarterly, \"this summer, pending regulatory review.\" On 2026-08-04 it reported record July ADV of 27 million contracts, +23% YoY, with international ADV +32% to 8.8 million. Yet the 2026-08-07 close of $263.66 sits 16.9% under the 52-week high of $317.22 and below the 200-day average at $278.50 (as of 2026-08-08). Operating records are landing without new price highs — that gap, and whether the sports/24-7 product pipeline clears the CFTC, is the whole question.\n\nLife-cycle: **MATURING**. Dating it: the Q2 beat on 2026-07-22 (adj EPS $2.99 vs $2.91 est., revenue $1.706B vs $1.685B est.) and the record-volume release on 2026-08-04 both arrived with the stock still down 5.8% over three months. The broader prediction-market theme has moved past discovery into regulatory attention — Bloomberg reported on 2026-08-07 that the CFTC warned prediction markets against \"American-style casino odds.\" Well known, still operationally working, flow moderating.\n\n## Bull Case\n- **2026-07-22 Q2 2026 print:** adjusted EPS $2.99 versus $2.91 consensus; revenue $1.706B versus $1.685B consensus. Shares traded higher that session (Benzinga, 2026-07-22).\n- **2026-08-04 volume release:** record July ADV of 27 million contracts, +23% YoY; international ADV +32% to 8.8 million. Growth is not confined to the US book.\n- **2026-07-29 FutureSports deal:** CME gains an exchange-listed, centrally cleared route into sports risk transfer — the segment where Kalshi, Polymarket and retail brokers currently hold distribution. FutureSports indexes convert league-approved statistics into rules-based, cash-settled benchmarks.\n- **Sell-side high end:** Morgan Stanley maintained Overweight and raised its target to $330 on 2026-07-23, after a cut to $324 on 2026-07-10. Piper Sandler carries Overweight at $295 (2026-07-15).\n- **Cash return intact:** $1.30 per share Q3 dividend declared 2026-08-06, payable 2026-09-25 to holders of record 2026-09-09. Trailing dividend $11.35 per share, 4.30% yield (as of 2026-08-08), inclusive of the January variable payout.\n- **Structure repaired at the short end:** the 2026-08-07 close of $263.66 sits above the 50-day average of $250.60.\n\n## Bear Case\n- **2026-07-09 regulatory block:** the CFTC issued a stay on CME's self-certified 24/7 crude oil futures listing (CFTC release 9265-26), pending review of whether round-the-clock crude trading is consistent with the Commodity Exchange Act. CME refiled under the Reg 40.3 voluntary-review path — up to 45 days, extendable to 90. Product velocity is regulator-paced.\n- **2026-08-07 stance on event contracts:** the CFTC's warning to prediction markets over casino-style odds (Bloomberg) lands two weeks before FSPI is meant to trade. The sports contract path is not clear runway.\n- **Multiple compression through good news:** despite the 07-22 beat and the 08-04 record month, the stock is -5.8% over three months and -16.9% from $317.22. The 50-day average ($250.60) sits well below the 200-day ($278.50) as of 2026-08-08 — the intermediate trend is still down and price is rallying into overhead.\n- **Dispersion at the low end:** BofA Securities maintained Underperform on 2026-07-23, raising its target only to $230 against the 2026-08-07 close of $263.66. Barclays holds Equal-Weight at $270 (2026-07-09).\n- **Operational overhang:** Reuters reported on 2026-08-06 that hackers targeted US financial firms including CME and Blackstone. No company disclosure quantifying impact appears in the filings record as of 2026-08-08.\n\n## Setup & Price Structure\n- Last completed daily close $263.66 (2026-08-07). 52-week high $317.22; distance from high -16.9%. Three-month return -5.8%.\n- RSI(14) 69.9 — short-term extended after a sharp recovery, arriving directly beneath resistance rather than out of a completed base.\n- Moving averages as of 2026-08-08: 50-day $250.60, 200-day $278.50. Price is between them. The 200-day is the gate; nothing about the intermediate structure resolves until it is closed above and held.\n- Overhead reference points above the 200-day: Piper Sandler $295 (2026-07-15), the 52-week high $317.22, Morgan Stanley $330 (2026-07-23). Beneath: the 50-day at $250.60, then BofA's $230 (2026-07-23).\n- Crowding/positioning observables: short interest 5.84 million shares, 1.65% of float (report date 2026-08-08) — no squeeze fuel. Published targets span $230 to $330, a wide spread that reads as disagreement rather than consensus positioning. No insider transactions appear in the recent filings record as of 2026-08-08. The next earnings print is roughly two and a half months out, so there is no imminent print compressing the window.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-26** — CFTC comment period closes on 24/7 futures trading and perpetual contracts for energy commodities (extended by the Commission). Determines the framework under which the stayed 24/7 crude listing can be relisted.\n- **~2026-08-31 (est.)** — first FSPI sports index futures listing, per the \"this summer, pending regulatory review\" language in the 2026-07-29 release. No contract specification date has been published as of 2026-08-08.\n- **~2026-09-02 (est.)** — August monthly volume/ADV release. July's landed 2026-08-04; the August print is the first test of whether the 27 million-contract record was episodic volatility or a run rate.\n- **2026-09-09 (just outside the window)** — dividend record date; payable 2026-09-25.\n- **~2026-10-21 (est.)** — Q3 2026 print, beyond the window. Last quarterly report was 2026-07-22.\n\n## What Would Change Our Mind\nThe recovery leg off the summer low is what makes this a live situation; it is undone if price hands back the short-term average it just reclaimed. A weekly close below $250 puts the tape back under its 50-day line and re-establishes the down-leg that took it 16.9% off the 52-week high.\n\nSeparately, the narrative leg fails on evidence rather than price if the FSPI sports index futures do not list by 2026-09-30 after the \"this summer\" guidance of 2026-07-29 — a slip past the quarter turns the sports story into a 2027 item. A third break: the August volume release (~2026-09-02, est.) printing ADV below July's 27 million with interest-rate ADV down year over year, which would argue the record was volatility rent rather than share gain.\n\nOn the other side, a weekly close above $278.50 that holds would flip the intermediate structure and put the 52-week high back in play; that has not happened as of 2026-08-07.\n\n## Correlation Notes\n- Revenue is a direct function of volatility across rates, energy and equity index. The name trades with expectations of Fed repricing and with realized rate vol; a settled policy path compresses the largest ADV complex regardless of new-product news.\n- Peer exchange complex — CBOE, ICE, NDAQ — carries the same volume-driven revenue structure; a peer's monthly volume release reads across to CME's.\n- Prediction-market and sports-betting complex: DraftKings and Flutter are the public read-through on sports event contracts; Kalshi and Polymarket are private and only observable through regulatory headlines like 2026-08-07.\n- Energy: WTI and Brent volatility drive the energy ADV line, and the stayed 24/7 listing is an energy-product question — an energy-vol spike raises both the volume line and the urgency of the CFTC decision.\n- Crypto: CME's bitcoin and ether futures ADV tracks crypto volatility, giving the name a secondary beta to digital-asset tape that peer exchanges carry less of.",
  "first_seen": "2026-07-31",
  "last_analyzed": "2026-08-08T07:26:16+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}